Persistent Tumor Mutational Burden (pTMB) May Predict Response to Immune Checkpoint Inhibitors

Katherine E.R. Smith; Svetomir N. Markovic

doi:10.1093/clinchem/hvad128

Persistent Tumor Mutational Burden (pTMB) May Predict Response to Immune Checkpoint Inhibitors

Katherine E.R. Smith, Svetomir N. Markovic

Hematology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	25-26
Number of pages	2
Journal	Clinical chemistry
Volume	70
Issue number	1
DOIs	https://doi.org/10.1093/clinchem/hvad128
State	Published - Jan 1 2024

ASJC Scopus subject areas

General Medicine

Access to Document

10.1093/clinchem/hvad128

Cite this

@article{7551af64a19341c69145fde45dc3cd34,

title = "Persistent Tumor Mutational Burden (pTMB) May Predict Response to Immune Checkpoint Inhibitors",

author = "Smith, {Katherine E.R.} and Markovic, {Svetomir N.}",

year = "2024",

month = jan,

day = "1",

doi = "10.1093/clinchem/hvad128",

language = "English (US)",

volume = "70",

pages = "25--26",

journal = "Clinical chemistry",

issn = "0009-9147",

publisher = "American Association for Clinical Chemistry Inc.",

number = "1",

}

TY - JOUR

T1 - Persistent Tumor Mutational Burden (pTMB) May Predict Response to Immune Checkpoint Inhibitors

AU - Smith, Katherine E.R.

AU - Markovic, Svetomir N.

PY - 2024/1/1

Y1 - 2024/1/1

UR - http://www.scopus.com/inward/record.url?scp=85181778016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85181778016&partnerID=8YFLogxK

U2 - 10.1093/clinchem/hvad128

DO - 10.1093/clinchem/hvad128

M3 - Article

C2 - 38175581

AN - SCOPUS:85181778016

SN - 0009-9147

VL - 70

SP - 25

EP - 26

JO - Clinical chemistry

JF - Clinical chemistry

IS - 1

ER -

Persistent Tumor Mutational Burden (pTMB) May Predict Response to Immune Checkpoint Inhibitors

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this